Literature DB >> 22503203

Extracorporeal membrane oxygenation after stage 1 palliation for hypoplastic left heart syndrome.

Elizabeth D Sherwin1, Kimberlee Gauvreau, Mark A Scheurer, Peter T Rycus, Joshua W Salvin, Melvin C Almodovar, Francis Fynn-Thompson, Ravi R Thiagarajan.   

Abstract

OBJECTIVE: To report the outcomes from a large multicenter cohort of neonates requiring extracorporeal membrane oxygenation (ECMO) after stage 1 palliation for hypoplastic left heart syndrome.
METHODS: Using data from the Extracorporeal Life Support Organization (2000-2009), we computed the survival to hospital discharge for neonates (age ≤30 days) supported with ECMO after stage 1 palliation for hypoplastic left heart syndrome. The factors associated with mortality were evaluated using multivariate logistic regression analysis.
RESULTS: Among 738 neonates, the survival rate was 31%. The median age at cannulation was 7 days (interquartile range, 4-11). Black race (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.2-3.6), mechanical ventilation before ECMO (>15-131 hours: OR, 1.6; 95% CI, 1.1-2.4; >131 hours: OR, 1.9; 95% CI, 1.3-2.9), use of positive end expiratory pressure (>6-8 cm H(2)O: OR, 1.7; 95% CI, 1.1-2.7; >8 cm H(2)O: OR, 1.9; 95% CI, 1.2-3.1), and longer ECMO duration (per day, OR, 1.2; 95% CI, 1.1-1.3) increased mortality. ECMO support for failure to wean from cardiopulmonary bypass (OR, 1.6; 95% CI, 1.02-2.4) also decreased survival. ECMO complications, including renal failure (OR, 1.9; 95% CI, 1.2-3.1), inotrope requirement (OR, 1.5; 95% CI, 1.1-2.1), myocardial stun (OR, 3.2; 95% CI, 1.3-7.7), metabolic acidosis (OR, 2.9; 95% CI, 1.3-6.7), and neurologic injury (OR, 1.7; 95% CI, 1.1-2.6), during support also increased mortality.
CONCLUSIONS: Mortality for neonates with hypoplastic left heart syndrome supported with ECMO after stage 1 palliation is high. Longer ventilation before cannulation, longer support duration, and ECMO complications increased mortality.
Copyright © 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22503203     DOI: 10.1016/j.jtcvs.2012.03.035

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  21 in total

1.  Norwood Procedure-Difficulty in Weaning From Cardiopulmonary Bypass and Implications for Outcomes.

Authors:  Jaclyn A Gellings; William K Johnson; Nancy S Ghanayem; Michael Mitchell; James Tweddell; George Hoffman; Viktor Hraska; Evelyn M Kuhn; Ronald K Woods
Journal:  Semin Thorac Cardiovasc Surg       Date:  2019-08-09

2.  Outcomes in Patients with Persistent Ventricular Dysfunction After Stage I Palliation for Hypoplastic Left Heart Syndrome.

Authors:  Emilie Jean-St-Michel; Devin Chetan; Steven M Schwartz; Glen S Van Arsdell; Alejandro A Floh; Osami Honjo; Jennifer Conway
Journal:  Pediatr Cardiol       Date:  2015-09-22       Impact factor: 1.655

3.  Efficacy of new pediatric extra-corporeal life support system (Endumo 2000) for postoperative management after Norwood operation.

Authors:  Takaya Hoashi; Koji Kagisaki; Takayuki Nishigaki; Kotaro Yoshida; Teruyuki Hayashi; Hajime Ichikawa
Journal:  J Artif Organs       Date:  2014-08-15       Impact factor: 1.731

Review 4.  Options for the failing ventricle in pediatric heart disease.

Authors:  Mazyar Kanani; Tain-Yen Hsia
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

5.  Racial and Ethnic Variation in Pediatric Cardiac Extracorporeal Life Support Survival.

Authors:  Titus Chan; Jane Di Gennaro; Reid W D Farris; Monique Radman; David Michael McMullan
Journal:  Crit Care Med       Date:  2017-04       Impact factor: 7.598

6.  Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry.

Authors:  Ryan P Barbaro; Folafoluwa O Odetola; Kelley M Kidwell; Matthew L Paden; Robert H Bartlett; Matthew M Davis; Gail M Annich
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

7.  Interstage Survival for Patients with Hypoplastic Left Heart Syndrome After ECMO.

Authors:  Richard P Fernandez; Brian F Joy; Robin Allen; Jamie Stewart; Holly Miller-Tate; Yongjie Miao; Lisa Nicholson; Clifford L Cua
Journal:  Pediatr Cardiol       Date:  2016-11-01       Impact factor: 1.655

8.  Myocardial oxidative metabolism and protein synthesis during mechanical circulatory support by extracorporeal membrane oxygenation.

Authors:  Colleen M O'Kelly Priddy; Masaki Kajimoto; Dolena R Ledee; Bertrand Bouchard; Nancy Isern; Aaron K Olson; Christine Des Rosiers; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-30       Impact factor: 4.733

9.  Racial Disparities in Hospital Mortality Among Pediatric Cardiomyopathy and Myocarditis Patients.

Authors:  Jillian Olsen; Yuen Lie Tjoeng; Joshua Friedland-Little; Titus Chan
Journal:  Pediatr Cardiol       Date:  2020-10-06       Impact factor: 1.655

10.  Pediatric and neonatal extracorporeal membrane oxygenation: does center volume impact mortality?*.

Authors:  Carrie L Freeman; Tellen D Bennett; T Charles Casper; Gitte Y Larsen; Ania Hubbard; Jacob Wilkes; Susan L Bratton
Journal:  Crit Care Med       Date:  2014-03       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.